Suppression of cell-mediated immunity by cyclophosphamide: Its independence of concomitant B cell response
- 31 December 1973
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 9 (3), 477-481
- https://doi.org/10.1016/0008-8749(73)90063-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Proportional Increase in the θ Carrying Lymphocytes in Peripheral Lymphoid Tissue following Treatment with CyclophosphamideNature New Biology, 1972
- Delayed hypersensitivity to azobenzenearsonate‐N‐acetyl‐L‐tyrosine. In vivo and in vitro studyEuropean Journal of Immunology, 1971
- CELL TO CELL INTERACTION IN THE IMMUNE RESPONSEThe Journal of Experimental Medicine, 1970
- Specific Tolerance to Sheep Erythrocytes in Mouse Bone Marrow CellsNature, 1969
- THE THYMUS AND RECOVERY FROM CYCLOPHOSPHAMIDE-INDUCED TOLERANCE TO SHEEP ERYTHROCYTESThe Journal of Experimental Medicine, 1968
- Enhancement of Dinitrochlorobenzene (DNCB) Contact Sensitization by Cyclophosphamide in the Guinea PigJournal of Investigative Dermatology, 1967
- Chemical Suppression of Adaptive ImmunityAdvances in Immunology, 1967
- IMMUNOCHEMICAL STUDY OF ANTIGENIC SPECIFICITY IN DELAYED HYPERSENSITIVITYThe Journal of Experimental Medicine, 1966
- THE SPECIFICITY OF ALLERGIC REACTIONSThe Journal of Experimental Medicine, 1964
- Effect of Cyclophosphoramide, 6-Mercaptopurine, Actinomycin D and Vincaleukoblastine on the Acquisition of Delayed Hypersensitivity (DNCB Contact Dermatitis) in the Guinea-Pig11From the Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia 4, Pennsylvania.This study was supported in part by U.S.P.H.S. Training Grant 2 G-62.This investigation was carried out during the tenure of a postdoctoral fellowship, held by Dr. Maibach, from the Division of General Medical Sciences, United States Public Health Service.Cyclophosphoramide (Cytoxan®) was supplied by Paul A. Walter, M.D., Mead Johnson Laboratories, Evansville 21, Indiana; 6-mercaptopurine by Donald S. Searle, M.D., Burroughs Wellcome & Co., Tuckahoe, N.Y.; vincaleukoblastine by J. A. Armstrong, M.D., Eli Lilly and Co., Indianapolis 6, Indiana; and Actinomycin D by Elmer Alpert, M.D., Merck Sharp and Dohme, West Point, Pa.Presented at the Twenty-second Annual Meeting of The Society for Investigative Dermatology, Inc., New York, N.Y., June 28, 1961.Journal of Investigative Dermatology, 1961